Cargando…
Taqman Assay for Genotyping CKD-Associated APOL1 SNP rs60910145: A Cautionary Note
Autores principales: | David, Victor A., Binns-Roemer, Elizabeth A., Winkler, Cheryl A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6308993/ https://www.ncbi.nlm.nih.gov/pubmed/30596185 http://dx.doi.org/10.1016/j.ekir.2018.09.018 |
Ejemplares similares
-
Impact of APOL1 Genetic Variants on HIV-1 Infection and Disease Progression
por: An, Ping, et al.
Publicado: (2019) -
APOL1 Risk Variants and Subclinical Cardiovascular Disease in Incident Hemodialysis Patients
por: Chen, Teresa K., et al.
Publicado: (2020) -
APOL1, Acid Load, and CKD Progression
por: Pike, Mindy, et al.
Publicado: (2019) -
SNP genotyping using TaqMan® technology: the CYP2D6*17 assay conundrum
por: Gaedigk, Andrea, et al.
Publicado: (2015) -
APOL1 Renal Risk Variants and Sickle Cell Trait Associations With Reduced Kidney Function in a Large Congolese Population-Based Study
por: Masimango, Mannix Imani, et al.
Publicado: (2021)